Hologic (NSDQ:HOLX) said yesterday that it inked an agreement with Dexa+ to distribute Hologic’s Horizon DXA system intended for body composition measurement.
Dexa+ works with U.S.-based healthcare practices to implement and optimize DXA technologies for integrative medicine, health and wellness programs, Marlborough, Mass.-based Hologic said.
Hologic said that it hopes the partnership will allow it to expand its expertise in body composition assessment and the reach of its DXA system.
“This is a great partnership as we share a vision for, and commitment to, DXA for comprehensive body composition assessment. The combination of our industry-leading Horizon DXA system with the deep expertise and reach of the Dexa+ channel will expand patient access to this game-changing technology that can complement wellness and training programs,” Hologic breast and skeletal health solutions division prez Pete Valenti said in a press release.
The companies did not release any details of the deal.
Earlier this month, Hologic posted fiscal year 2019 second quarter earnings that topped expectations on Wall Street and lifted its guidance for the remaining fiscal year.